These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 32339344)

  • 1. Vascular skin symptoms in COVID-19: a French observational study.
    Bouaziz JD; Duong TA; Jachiet M; Velter C; Lestang P; Cassius C; Arsouze A; Domergue Than Trong E; Bagot M; Begon E; Sulimovic L; Rybojad M
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e451-e452. PubMed ID: 32339344
    [No Abstract]   [Full Text] [Related]  

  • 2. Widespread cutaneous small vessel vasculitis secondary to COVID-19 infection.
    Tahir A; Sohail Z; Nasim B; Parmar NV
    Int J Dermatol; 2020 Oct; 59(10):1278-1279. PubMed ID: 32880974
    [No Abstract]   [Full Text] [Related]  

  • 3. Symmetric cutaneous vasculitis in COVID-19 pneumonia.
    Castelnovo L; Capelli F; Tamburello A; Faggioli PM; Mazzone A
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e362-e363. PubMed ID: 32378747
    [No Abstract]   [Full Text] [Related]  

  • 4. Recognizable vascular skin manifestations of SARS-CoV-2 (COVID-19) infection are uncommon in patients with darker skin phototypes.
    Pangti R; Gupta S; Nischal N; Trikha A
    Clin Exp Dermatol; 2021 Jan; 46(1):180-182. PubMed ID: 32803786
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature.
    Matar S; Oulès B; Sohier P; Chosidow O; Beylot-Barry M; Dupin N; Aractingi S
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):e686-e689. PubMed ID: 32589293
    [No Abstract]   [Full Text] [Related]  

  • 6. Granuloma annulare triggered by SARS-CoV-2 infection. The first reported case.
    García-Gil MF; Monte Serrano J; García García M; Matovelle Ochoa C; Ara-Martín M
    J Dermatol; 2021 Jan; 48(1):e1-e2. PubMed ID: 33169426
    [No Abstract]   [Full Text] [Related]  

  • 7. SARS-CoV-2 nosocomial infection acquired in a French university hospital during the 1st wave of the Covid-19 pandemic, a prospective study.
    Landoas A; Cazzorla F; Gallouche M; Larrat S; Nemoz B; Giner C; Le Maréchal M; Pavese P; Epaulard O; Morand P; Mallaret MR; Landelle C
    Antimicrob Resist Infect Control; 2021 Aug; 10(1):114. PubMed ID: 34353356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous Endothelial Dysfunction and Complement Deposition in COVID-19.
    Tammaro A; Adebanjo GAR; Del Nonno F; Pezzuto A; Ramirez-Estrada S; Parisella FR; Rello J; Scarabello A
    Am J Dermatopathol; 2021 Mar; 43(3):237-238. PubMed ID: 33055532
    [No Abstract]   [Full Text] [Related]  

  • 9. Urticaria in the times of COVID-19.
    Kaushik A; Parsad D; Kumaran MS
    Dermatol Ther; 2020 Nov; 33(6):e13817. PubMed ID: 32531079
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cutaneous lesions in COVID-19 patients].
    Çiftçi Z; Clabbers JMK; Galimont-Collen AFS; Gostyński A
    Ned Tijdschr Geneeskd; 2020 Dec; 164():. PubMed ID: 33332042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acro-ischaemia in hospitalized COVID-19 patients.
    Suarez-Valle A; Fernandez-Nieto D; Diaz-Guimaraens B; Dominguez-Santas M; Carretero I; Perez-Garcia B
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e455-e457. PubMed ID: 32378743
    [No Abstract]   [Full Text] [Related]  

  • 12. First detection and genome sequencing of SARS-CoV-2 in an infected cat in France.
    Sailleau C; Dumarest M; Vanhomwegen J; Delaplace M; Caro V; Kwasiborski A; Hourdel V; Chevaillier P; Barbarino A; Comtet L; Pourquier P; Klonjkowski B; Manuguerra JC; Zientara S; Le Poder S
    Transbound Emerg Dis; 2020 Nov; 67(6):2324-2328. PubMed ID: 32500944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection in breast carcinoma patients.
    Adamopoulou M; Manaios L; Papouliakos S; Tsiambas E
    J BUON; 2021; 26(5):2207-2208. PubMed ID: 34761644
    [No Abstract]   [Full Text] [Related]  

  • 14. SARS-CoV-2 as a Trigger for De Novo Ulcerative Colitis.
    Imperatore N; Bennato R; D'Avino A; Lombardi G; Manguso F
    Inflamm Bowel Dis; 2021 Jun; 27(7):e87-e88. PubMed ID: 33616182
    [No Abstract]   [Full Text] [Related]  

  • 15. Considerations for the treatment of esophageal cancer during the COVID-19 pandemic.
    Davakis S; Karamouzis M; Ziogas D; Charalabopoulos A
    J BUON; 2021; 26(3):1171. PubMed ID: 34268989
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune Thrombocytopenic Purpura in a Child Following a SARS-CoV-2 Infection.
    Sivasankaran M; Siva Balan S; Munirathnam D
    J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1268-e1269. PubMed ID: 34673716
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate cancer and SARS-CoV-2: possible intersections through the TMPRSS2 pathway.
    Porcacchia AS; Andersen ML; Tufik S
    Eur J Cancer Prev; 2021 Nov; 30(6):481-483. PubMed ID: 34596106
    [No Abstract]   [Full Text] [Related]  

  • 18. Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 Can Be Divided Into Inflammatory and Vascular Patterns [Formula: see text].
    Naderi-Azad S; Vender R
    J Cutan Med Surg; 2021; 25(2):169-176. PubMed ID: 33179534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grover-like skin eruption: another cutaneous manifestation in a COVID-19 patient.
    Boix-Vilanova J; Gracia-Darder I; Saus C; Ramos D; Llull A; Santonja C; Del Pozo LJ; Martín-Santiago A
    Int J Dermatol; 2020 Oct; 59(10):1290-1292. PubMed ID: 32880914
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral vesiculobullous lesions as an early sign of COVID-19: immunohistochemical detection of SARS-CoV-2 spike protein.
    Soares CD; Mosqueda-Taylor A; de Carvalho MGF; de Almeida OP
    Br J Dermatol; 2021 Jan; 184(1):e6. PubMed ID: 33140407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.